Ryman Healthcare logo

RYM - Ryman Healthcare Share Price

NZD14.88 0.2  1.6%

Last Trade - 3:59am

Sector
Healthcare
Size
Large Cap
Market Cap £3.83bn
Enterprise Value £4.95bn
Revenue £230.6m
Position in Universe 86th / 1832
Bullish
Bearish
Unlock RYM Revenue
Momentum
Relative Strength (%)
1m -6.16%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.55%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
227.1 261.1 289.2 342.5 382.3 423.9 578.5 646.4 +13.3%
+24.1 +26.3 +16.7 +8.8 -16.0 -18.9 -5.10 +20.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020, RymanHealthcare Ltd. revenues increased 7% to NZ$222.1M. Netincome increased 13% to NZ$212.4M. Revenues reflectAustralia segment increase of 88% to NZ$24.3M, New Zealandsegment increase of 2% to NZ$197.8M. Net income benefitedfrom FV Movement of Investment Properties increase of 12%to NZ$201.1M (income). Dividend per share decreased fromNZ$0.08 to NZ$0.06.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RYM Revenue Unlock RYM Revenue

Net Income

RYM Net Income Unlock RYM Revenue

Normalised EPS

RYM Normalised EPS Unlock RYM Revenue

PE Ratio Range

RYM PE Ratio Range Unlock RYM Revenue

Dividend Yield Range

RYM Dividend Yield Range Unlock RYM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RYM EPS Forecasts Unlock RYM Revenue
Profile Summary

Ryman Healthcare Limited develops, owns and operates integrated retirement villages, resthomes and hospitals for the elderly people. The Company offers various living and care options, including independent living, assisted living, resthome, hospital and dementia. The independent townhouses and apartments are occupied by residents wishing to retain a level of independence. The Company's Assisted Living offers a range of services, including meals, housekeeping services, morning and afternoon tea, shopping trips and the resort style facilities offered by the village. Resthome and Hospital level care in its Village offers residents in clinical care. The Company offers a specialized care unit for residents. The Company's Villages include residents requiring short-term care, respite care and day care. The Company also offers Day Care program for those just needing assistance during the day. The Company operates in New Zealand with various operations in Australia.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated May 8, 1987
Public Since June 25, 1999
No. of Shareholders: n/a
No. of Employees: 1,400
Sector Healthcare
Industry Healthcare Providers & Services
Index FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan ,
Exchange New Zealand Stock Exchange
Shares in Issue 497,288,756
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RYM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RYM
Upcoming Events for RYM
Frequently Asked Questions for Ryman Healthcare
What is the Ryman Healthcare share price?

As of 3:59am, shares in Ryman Healthcare are trading at NZD14.88, giving the company a market capitalisation of £3.83bn. This share price information is delayed by 15 minutes.

How has the Ryman Healthcare share price performed this year?

Shares in Ryman Healthcare are currently trading at NZD14.88 and the price has moved by -7.86% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ryman Healthcare price has moved by -10.56% over the past year.

What are the analyst and broker recommendations for Ryman Healthcare?

Of the analysts with advisory recommendations for Ryman Healthcare, there are there are currently 0 "buy" , 3 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Ryman Healthcare is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Ryman Healthcare next release its financial results?

Ryman Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Ryman Healthcare dividend yield?

The Ryman Healthcare dividend yield is 0.98% based on the trailing twelve month period.

Does Ryman Healthcare pay a dividend?

Last year, Ryman Healthcare paid a total dividend of 0.14, and it currently has a trailing dividend yield of 0.98%. Looking ahead, Ryman Healthcare has not announced an ex-dividend date yet.

When does Ryman Healthcare next pay dividends?

Ryman Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on Ryman Healthcare shares is currently 0.98%.

How do I buy Ryman Healthcare shares?

To buy shares in Ryman Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ryman Healthcare?

Shares in Ryman Healthcare are currently trading at NZD14.88, giving the company a market capitalisation of £3.83bn.

Where are Ryman Healthcare shares listed? Where are Ryman Healthcare shares listed?

Here are the trading details for Ryman Healthcare:

Country of listing: New Zealand
Exchange: NZC
Ticker Symbol: RYM
What kind of share is Ryman Healthcare?

Based on an overall assessment of its quality, value and momentum, Ryman Healthcare is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Ryman Healthcare share price forecast 2021?

Shares in Ryman Healthcare are currently priced at NZD14.88. At that level they are trading at 4.21% premium to the analyst consensus target price of 0.00.

Analysts covering Ryman Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 0.502 for the next financial year.

How can I tell whether the Ryman Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ryman Healthcare. Over the past six months, the relative strength of its shares against the market has been -2.34%. At the current price of NZD14.88, shares in Ryman Healthcare are trading at 3.71% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ryman Healthcare PE Ratio?

The Ryman Healthcare PE ratio based on its reported earnings over the past 12 months is 25.37. The shares are currently trading at NZD14.88.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Ryman Healthcare?

Ryman Healthcare's management team is headed by:

David Kerr - NEC
Tom Brownrigg - OTH
Gordon MacLeod - CEO
Jo Appleyard - NID
Warren Bell - NID
Nicole Forster - CHO
David Michael Bennett - CFO
Geoffrey Cumming - NED
Cheyne Chalmers - COO
Paula Jeffs - DRC
Jeremy Moore - OTH
Mary-Anne Stone - OTH
Who are the major shareholders of Ryman Healthcare?

Here are the top five shareholders of Ryman Healthcare based on the size of their shareholding:

Cumming (Geoffrey Alexander) Individual Investor
Percentage owned: 9.74% (48.7m shares)
Hickman Family Trustees Ltd. Corporation
Percentage owned: 6.6% (33.0m shares)
GANÉ Aktiengesellschaft Investment Advisor
Percentage owned: 4.7% (23.5m shares)
ACATIS GANE VALUE EVENT FONDS Mutual Fund
Percentage owned: 4.7% (23.5m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.23% (11.1m shares)
Similar to RYM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.